Mualliflar

  • Abdulkhamidov A.A.

##semicolon##

supraventricular arrhythmia; supraventricular tachycardia; radiofrequency catheter ablation; sympathoadrenal system; catecholamines; heart rate variability; monoamine oxidase; vanillylmandelic acid; oxidative stress.

##submission.citations##

1. Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomström-Lundqvist C, et al. 2019 ESC Gui-delines for the management of patients with supra-ventricular tachycardia. European Heart Journal. 20 20;41(5):655–720. doi:10.1093/eurheartj/ehz467.

2. Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, et al. 2024 ESC Guidelines for the management of atrial fibrillation. European Heart Journal. 2024;45(36):3314–3414. doi:10.1093/eurheartj/ehae176.

3. Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS Guideline for the management of adult patients with supraventricular tachycardia. Circulation. 2016;133(14): e506–e574. doi:10.1161/CIR.0000000000000311.

4. Delacrétaz E. Supraventricular tachycardia. New England Journal of Medicine. 2006;354 (10):1039–1051. doi:10.1056/NEJMcp051145.

5. Katritsis DG, Camm AJ. Atrioventricular nodal reentrant tachycardia. Circulation. 2010;122 (8):831–840. doi:10.1161/CIRCULATIONAHA.110.9 36591.

6. Katritsis DG, Josephson ME. Classification, electrophysiological features and therapy of atrioventricular nodal reentrant tachycardia. Arrhythmia & Electrophysiology Review. 2016;5(2):130–135. doi:10.15420/AER.2016.18.2.

7. Huang SKS, Miller JM, editors. Catheter Ablation of Cardiac Arrhythmias. 4th ed. Philadelphia: Elsevier; 2020.

8. Yan GX, Kowey PR, Antzelevitch C, editors. Management of Cardiac Arrhythmias. 3rd ed. Cham: Humana Press/Springer; 2020. doi:10.1007/978-3-030-41967-7.

9. Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circulation Research. 2014;114(6):1004–1021. doi: 10.1161/CIRCRESAHA.113.302549.

10. Goldberger JJ, Arora R, Buckley U, Shivkumar K. Autonomic nervous system dysfunction: JACC focus seminar. Journal of the American College of Cardiology. 2019;73(10):1189–1206. doi: 10.1016/ j.jacc.2018.12.064.

11. Stavrakis S, Kulkarni K, Singh JP, Katritsis DG, Armoundas AA. Autonomic modulation of cardiac arrhythmias: methods to assess treatment and outcomes. JACC: Clinical Electrophysiology. 2020; 6(5):467–483. doi:10.1016/j.jacep.2020.02.014.

12. Malik M, Bigger JT, Camm AJ, Kleiger RE, Malliani A, Moss AJ, Schwartz PJ. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93(5): 1043–1065. doi: 10.1161/01.CIR.93.5.1043.

13. Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Frontiers in Public Health. 2017; 5:258. doi:10.3389/fpubh.2017. 00258.

14. Emkanjoo Z, Alasti M, Arya A, et al. Heart rate variability: does it change after RF ablation of reentrant supraventricular tachycardia? Journal of Interventional Cardiac Electrophysiology. 2005;14 (3):147–151. doi:10.1007/s10840-006-4836-y.

15. Psychari SN, Theodorakis GN, Koutelou MG, Livanis EG, Kremastinos DT. Cardiac denervation after radiofrequency ablation of supraventricular tachycardias. American Journal of Cardiology. 1998;81(6):725–731. doi:10.1016/S0002-9149(97) 01008-4.